With over a century of experience in surgical innovation, Johnson & Johnson MedTech is proud to be the official sponsor of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Our commitment is to transform modern surgery by driving advancements that improve the quality of life for millions of patients and make the work of healthcare professionals easier worldwide.

From our beginnings, we have been deeply dedicated to the people we serve, developing technologies and solutions that humanize the surgical experience. Today, at J&J MedTech, we are leading a new era in surgery, focused on better connecting patients and professionals, personalizing care, and making each intervention more beneficial for everyone.

As a global leader in MedTech, we work closely with physicians and health experts to tackle critical challenges, such as metabolic diseases. Our ongoing innovation aims to create safe, effective, and human-centered surgical solutions that foster positive outcomes and promote high-quality care. Proud to be part of the IFSO community, we support research, education, and the dissemination of knowledge in obesity surgery and metabolic disorders, advancing a humanitarian approach that places people at the center of all our actions.